Exports of medical devices will profit from Sub-Saharan Africa’s fast economic growth, which is being backed by rising commodity prices and a rise in investor confidence, even if the area is still extremely exposed to political unpredictability. The main business center for Sub-Saharan Africa’s medical device sector is located in South Africa.
Exports of the lab and medical equipment make up a significant component of goods going to other African countries. For the MEA area, spending on medical equipment as a percentage of wealth is around average.
A little over forty per cent of the market is made up of other medical gadgets. Its tremendous development potential stems from its status as a developing market.
The South Africa Medical Devices Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.
To assist with COVID-19 patient triage and monitoring using X-ray imaging, Philips Foundation has successfully introduced artificial intelligence (AI) software created by Delft Imaging in 11 South African hospitals.
The AI-based CAD4COVID software from Delft Imaging evaluates the severity and course of COVID-19 illness using commonly available chest X-rays as a supplement to existing COVID-19 diagnostic methods.
To assist COVID-19 patient triaging in resource-constrained settings and high-prevalence locations, CAD4COVID has been created and is available for free usage.
The method is based on the same technical foundation as the CAD4TB TB detection software from Delft Imaging, which has helped screen six million individuals for TB globally.
The solution’s capacity to lessen the stress on healthcare institutions without the resources to handle the surge of COVID-19 patients as well as its capacity to lighten the workload of frontline healthcare personnel were both acknowledged by the Philips Foundation.
The Philips Foundation has funded the introduction of CAD4COVID in 11 South African institutions as part of its aim to help underserved populations have access to high-quality healthcare.
Sonoma Pharmaceuticals, Inc., a leader in global healthcare that develops and manufactures stabilized hypochlorous acid (HOCl) products based on the patented Microcyn technology for a variety of uses, including wound, eye, oral and nasal care, and dermatological conditions, announced that it has introduced Microdox, a catheter and bladder rinse for urinary tract infections, in New Zealand, Australia, and South Africa. Microdox is a readily available, non-irritating, and non-toxic solution.
Following the start of an additive manufacturing project in Bloemfontein, South Africa won’t have to rely on expensive imported medical devices for people with disabilities. One of the technologies utilized in advanced manufacturing and regarded as a cornerstone of the fourth industrial revolution is additive manufacturing, also known as 3D printing.
The project was supported by the DSI through its subsidiary, the Technology Innovation Agency (TIA), which offers technical assistance to small and medium-sized businesses connected to a technology station at CUT. By utilizing the benefits that additive manufacturing brings to the manufacturing industry, the MedAdd project has been effective in closing the innovation gap for medical device companies.
The president of South Africa recently inaugurated a new vaccine production facility in Cape Town. The Accelerate Africa’s Access to Advanced Healthcare (AAAH) alliance, which intends to produce a billion doses of the COVID-19 vaccine by 2025 as well as build production facilities for advanced biologics in sub-Saharan Africa, was launched in conjunction with the campus’s official opening.
Additionally, it seeks to develop novel manufacturing methods to deliver fresh therapies for diseases including cancer, TB, and HIV/AIDS. An updated COVID-19 vaccination will be one of its initial initiatives.
According to WHO’s global classification system for national medical product regulatory authorities, South Africa’s vaccine regulatory system has a functional level of maturity. This acknowledges that South Africa has a reliable, efficient, and comprehensive regulatory system in place to guarantee the efficacy, safety, and high quality of vaccines produced, imported, or dispensed within the nation.
The third of the four levels in the WHO categorization, maturity level three (ML3), was officially attained by the nation. The highest maturity level is level four (ML4).
Sections 18A and 18B of the Medicines and Related Substances Act are not applicable to medical devices and in-vitro diagnostics under the currently in place exemption. This extension allows manufacturers of medical devices and in-vitro diagnostics to continue selling their goods under bonus, rebate, and incentive programmes for a further three years.
The Medical Device Manufacturers of South Africa (MDMSA) is a grouping of businesses that produce medical equipment in South Africa. It is a SAMED organisation member that only speaks for local manufacturers. The purpose of MDMSA is to help members compete globally and increase the local produced content of this industry sector within South Africa.
In doing so, MDMSA collaborates closely with the Department of Health and the Department of Trade and Industry (The dti) in order to make the most of the numerous resources available in order to support the government-designated priority area of medical technology.
The revolutionary medical device startup CapeRay is working on a number of technologies to assist professionals more easily identify breast cancer. Its debut item, Aceso, a dual-modality system that combines full-field digital mammography (a low energy x-ray) and automated breast ultrasonography into one unit, was named after the Greek goddess of healing.
In just ten minutes, this makes it possible to simultaneously acquire two sets of breast imaging from two viewpoints, enhancing diagnostic accuracy in dense breasts.
The medical device company, which focuses on spinal systems, works with surgeons to develop new technologies and techniques or to enhance those that already exist in order to advance the medical field.
With CE and US Food and Drug Administration accreditation, Ti-TaMED has created its own line of proprietary spinal implants that enable both general spinal fusions and a novel scoliosis treatment procedure.
Stents and vascular technology for the treatment of coronary artery disease have been developed by DISA Vascular for the global medical market.
All of its products bear the CE mark and have received regulatory approval in a number of other non-European countries. Utilizing the most recent technology available, the South African research and development company manufactures its products in Germany.
A tiny chest drainage device created by Sinapi keeps all uses for draining chest fluids after heart, lung, and trauma surgery while allowing for more patient mobility.
The business asserts that its mechanical (Scheffler) valve is more effective than current systems, permitting quicker evacuation of blood and air from the chest, shortening chest drainage time, enabling quicker removal of the chest catheter, and improving patient outcomes.
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.